# Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-

> **NCT01129596** · — · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 10238 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** donepezil hydrochloride

## Key facts

- **NCT ID:** NCT01129596
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06-10
- **Primary completion:** 2015-09-25
- **Final completion:** 2016-06-23
- **Target enrollment:** 10238 (ACTUAL)
- **Last updated:** 2018-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01129596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01129596, "Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01129596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*